Table 2.
Characteristics of Included Research Protocols for Nonpharmacological Behavioral Interventions (N = 7)
| Author, Year, and Sample | Age and Gender | Country | Design | Intervention | Outcome |
|---|---|---|---|---|---|
| Côté et al., 2015 (n = 750) | 18+; gender not specified | Canada | RCT | 6-month web-based health promotion and behavior change intervention | Adoption of health behaviors (smoking cessation, physical activity, or healthy eating) |
| Mitrani, 2019 (n = 18) | 50+; men | USA | Feasibility Study | 16-week multicomponent, social and physical activity intervention | Feasibility of recruitment, retention rate, and acceptability of intervention |
| Nieuwkerk, 2014 (n = 250) | 181; gender not specified | The Netherlands | RCT | 12-month CVD risk communication tool intervention | 5-year absolute CVD-risk score |
| Okeke, 2019 (n = 50) | 40–75; open to all genders | USA | RCT | 24-week case manager/social worker-delivered telephone intervention | Change in ambulatory SBP and change in fasting LDL-c levels |
| Saumoy, 2012 (n = 54) | 18+; men and women | Spain | RCT | 55-month intensive, multidisciplinary lifestyle intervention delivered by preventative health physician and dietician | Changes in lipid parameters and Framingham score |
| Stradling et al., 2016 (n = 60) | Adults; gender not specified | United Kingdom | RCT | 12-month dietary intervention | Feasibility and acceptability of trial procedures for recruitment, retention, data completion, and the intervention |
| Waldrop-Valverde, 2016 (n = 115) | 50–75; open to all genders | USA | RCT | 12-week in-home walking program | Improvement in memory, concentration thinking abilities, physical function, and quality of life |
Note. CVD = cardiovascular disease; LDL-c = low density lipoprotein cholesterol; RCT = randomized control trial; SBP = systolic blood pressure.